Tuesday, 3 November 2015

Medicare Sets Pricing Plan For Biotech Copycat Drugs

In other regulatory news, Medicare continues its scrutiny of short hospital stays, new patient protections for transgender people are imminent, the FDA considers further regulation of HIV drugs and a battle continues over a federal drug discount program.

No comments:

Post a Comment